Genenta Science S.p.A.
GNTAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Genenta Science S.p.A. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 5, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| UBS Group AG | 2026-03-31 | 3,107 | Not shown | SEC filing |
| AlTi Global, Inc. | 2026-03-31 | 200,288 | Not shown | SEC filing |
| SmartHarvest Portfolios, LLC | 2026-03-31 | 134,447 | Not shown | SEC filing |
| Simplicity Wealth,LLC | 2026-03-31 | 12,211 | Not shown | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 15,420 | Not shown | SEC filing |
| Allianz SE | 2026-03-31 | 234,050 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 3 | Not shown | SEC filing |
| Independent Advisor Alliance | 2026-03-31 | 37,036 | Not shown | SEC filing |
| GAMMA Investing LLC | 2026-03-31 | 14,288 | Not shown | SEC filing |
| Eurizon Capital SGR S.p.A. | 2026-03-31 | 360,000 | Not shown | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 24,527 | Not shown | SEC filing |
| ALGEBRIS (UK) LTD | 2025-12-31 | 100,000 | Not shown | SEC filing |
| CITADEL ADVISORS LLC | 2025-12-31 | 655,164 | Not shown | SEC filing |
| SmartHarvest Portfolios, LLC | 2025-12-31 | 17,781 | Not shown | SEC filing |
| Weiss Asset Management LP | 2025-12-31 | 322,026 | Not shown | SEC filing |
| Alyeska Investment Group, L.P. | 2025-12-31 | 219,838 | Not shown | SEC filing |
| GAMMA Investing LLC | 2025-12-31 | 2,827 | Not shown | SEC filing |
| MORGAN STANLEY | 2025-12-31 | 45,900 | Not shown | SEC filing |
| NORGES BANK | 2025-12-31 | 226,178 | Not shown | SEC filing |
| Farther Finance Advisors, LLC | 2025-12-31 | 3 | Not shown | SEC filing |
- Each value is checked against Genenta Science S.p.A.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Eurizon Capital SGR S.p.A.: 360,000 shares reported 2025-12-31; 360,000 shares reported 2026-03-31.
- GAMMA Investing LLC: 2,827 shares reported 2025-12-31; 14,288 shares reported 2026-03-31.
- Farther Finance Advisors, LLC: 3 shares reported 2025-12-31; 3 shares reported 2026-03-31.
- Allianz SE: 234,050 shares reported 2025-12-31; 234,050 shares reported 2026-03-31.
- SmartHarvest Portfolios, LLC: 17,781 shares reported 2025-12-31; 134,447 shares reported 2026-03-31.
- AlTi Global, Inc.: 200,288 shares reported 2025-12-31; 200,288 shares reported 2026-03-31.
- UBS Group AG: 3,416 shares reported 2025-12-31; 3,107 shares reported 2026-03-31.
- Allianz SE: 234,050 shares reported 2025-09-30; 234,050 shares reported 2025-12-31.
- AlTi Global, Inc.: 200,288 shares reported 2025-09-30; 200,288 shares reported 2025-12-31.
- UBS Group AG: 91 shares reported 2025-03-31; 3,416 shares reported 2025-12-31.
- NATIONAL BANK OF CANADA /FI/: 3,000 shares reported 2025-09-30; 2,668 shares reported 2025-12-31.
- CITADEL ADVISORS LLC: 12,486 shares reported 2025-09-30; 655,164 shares reported 2025-12-31.
Showing the 12 most recent filer reports.
8 filers have only one report here.
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-30 | Paracchi Pierluigi · Chief Executive Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +100,000 | SEC filing |
| 2026-03-30 | Sharei Armon · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-03-30 | Mutti Miguel Maria · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-03-30 | SLANSKY RICHARD B · Chief Financial Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +80,000 | SEC filing |
| 2026-03-30 | PARACCHI GIACOMOANTONIO · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-03-30 | Galimi Francesco · CMO& Head of Development | Stock Option (right to buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
Showing 6 of 6 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.